Overexpression of Hif-1α in Mesenchymal Stem Cells Affects Cell-Autonomous Angiogenic and Osteogenic Parameters

Journal of Cellular Biochemistry

Volumn 117, Issue 3, 2016, Pages 760-768

  Lampert, F M ^a   Kutscher C ^a   Stark, G B ^a   Finkenzeller, G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ADENOVIRUS; ANGIOGENESIS; Hif 1 ; MIGRATION; OSTEOGENESIS

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR RUNX2; HIF1A PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS;

EID: 84955720630     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25361     Document Type: Article

References (41)

1. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S,. 1998. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16: 155-162.
2. Caplan AI, Hariri R,. 2015. Body management: Mesenchymal stem cells control the internal regenerator. Stem Cells Transl Med. [Epub ahead of print].
3. Cerrada I, Ruiz-Sauri A, Carrero R, Trigueros C, Dorronsoro A, Sanchez-Puelles JM, Diez-Juan A, Montero JA, Sepulveda P,. 2013. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair. Stem Cells Dev 22: 501-511.
4. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E,. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
5. Gazit D, Turgeman G, Kelley P, Wang E, Jalenak M, Zilberman Y, Moutsatsos I,. 1999. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J Gene Med 1: 121-133.
6. Grayson WL, Zhao F, Bunnell B, Ma T,. 2007. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358: 948-953.
7. Guo AJ, Choi RC, Cheung AW, Chen VP, Xu SL, Dong TT, Chen JJ, Tsim KW,. 2011. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: An action via the Wnt/beta-catenin signaling pathway. J Biol Chem 286: 27882-27893.
8. Hebert TL, Wu X, Yu G, Goh BC, Halvorsen YD, Wang Z, Moro C, Gimble JM,. 2009. Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med 3: 553-561.
9. Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, Muller I,. 2010. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 11: 11.
10. Huang X, Le QT, Giaccia AJ,. 2010. MiR-210?micromanager of the hypoxia pathway. Trends Mol Med 16: 230-237.
11. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG, Jr,. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468.
12. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL,. 1996. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778.
13. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L,. 1998. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 17: 6573-6586.
14. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L,. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274: 6519-6525.
15. Kiani AA, Kazemi A, Halabian R, Mohammadipour M, Jahanian-Najafabadi A, Roudkenar MH,. 2013. HIF-1alpha confers resistance to induced stress in bone marrow-derived mesenchymal stem cells. Arch Med Res 44: 185-193.
16. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, et al., 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49: 328-337.
17. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW,. 2004. Hypoxia-inducible factor (HIF-1) alpha: Its protein stability and biological functions. Exp Mol Med 36: 1-12.
18. Liao D, Johnson RS,. 2007. Hypoxia: A key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26: 281-290.
19. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ,. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
20. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN,. 2000. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 98: 9-20.
21. Mehlhorn AT, Schmal H, Kaiser S, Lepski G, Finkenzeller G, Stark GB, Sudkamp NP,. 2006. Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng 12: 1393-1403.
22. Minchenko A, Bauer T, Salceda S, Caro J,. 1994. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374-379.
23. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, Semenza GL,. 2006. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281: 15554-15563.
24. Peng L, Shu X, Lang C, Yu X,. 2015. Effects of hypoxia on proliferation of human cord blood-derived mesenchymal stem cells. Cytotechnology. [Epub ahead of print].
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
26. Raheja LF, Genetos DC, Wong A, Yellowley CE,. 2011. Hypoxic regulation of mesenchymal stem cell migration: The role of RhoA and HIF-1alpha. Cell Biol Int 35: 981-989.
27. Razban V, Lotfi AS, Soleimani M, Ahmadi H, Massumi M, Khajeh S, Ghaedi M, Arjmand S, Najavand S, Khoshdel A,. 2012. HIF-1alpha overexpression induces angiogenesis in mesenchymal stem cells. Biores Open Access 1: 174-183.
28. Riddle RC, Khatri R, Schipani E, Clemens TL,. 2009. Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling. J Mol Med (Berl) 87: 583-590.
29. Shieh SJ, Vacanti JP,. 2005. State-of-the-art tissue engineering: From tissue engineering to organ building. Surgery 137: 1-7.
30. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M,. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.
31. Sun X, Wei Y,. 2009. The role of hypoxia-inducible factor in osteogenesis and chondrogenesis. Cytotherapy 11: 261-267.
32. Towler DA,. 2007. Vascular biology and bone formation: Hints from HIF. J Clin Invest 117: 1477-1480.
33. Tsai CC, Chen YJ, Yew TL, Chen LL, Wang JY, Chiu CH, Hung SC,. 2011. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 117: 459-469.
34. Wagegg M, Gaber T, Lohanatha FL, Hahne M, Strehl C, Fangradt M, Tran CL, Schonbeck K, Hoff P, Ode A, et al., 2012. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner. PLoS ONE 7: e46483.
35. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM,. 1994. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76: 579-592.
36. Wang GL, Jiang BH, Rue EA, Semenza GL,. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514.
37. Wang GL, Semenza GL,. 1995. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237.
38. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, et al., 2007. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117: 1616-1626.
39. Wouters BG, Koritzinsky M,. 2008. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8: 851-864.
40. Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC,. 2011. Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST. PLoS ONE 6: e23965.
41. Zou D, Zhang Z, Ye D, Tang A, Deng L, Han W, Zhao J, Wang S, Zhang W, Zhu C, et al., 2011. Repair of critical-sized rat calvarial defects using genetically engineered bone marrow-derived mesenchymal stem cells overexpressing hypoxia-inducible factor-1alpha. Stem Cells 29: 1380-1390.